Document:

Amended and Restated 1993 Employee Stock Purchase Plan

 Exhibit 10.5 
 DSP GROUP, INC. 
 1993 EMPLOYEE STOCK PURCHASE PLAN 

(as amended and restated effective March 2011) 
 The following constitute the provisions of the 1993 Employee Stock Purchase Plan of DSP Group, Inc. 
 1. Purpose. The purpose of the Plan is to provide employees of the Company and its Designated Subsidiaries with an opportunity to purchase Common Stock of the Company through accumulated payroll
deductions. It is the intention of the Company to have the Plan qualify as an “Employee Stock Purchase Plan” under Section 423 of the Internal Revenue Code of 1986, as amended. The provisions of the Plan, accordingly, shall be
construed so as to extend and limit participation in a manner consistent with the requirements of that section of the Code. 

2. Definitions. 
 (a) “Board” shall mean the Board of Directors of the Company. 

(b) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(c) “Common Stock” shall mean the Common Stock of the Company. 

(d) “Company” shall mean DSP Group, Inc., a Delaware corporation. 

(e) “Compensation” shall mean all base straight time gross earnings, exclusive of payments for overtime, shift premium,
incentive compensation, incentive payments, bonuses, commissions and other compensation. 
 (f) “Designated
Subsidiaries” shall mean the Subsidiaries which have been designated by the Board from time to time in its sole discretion as eligible to participate in the Plan. 
 (g) “Employee” shall mean any individual who is an Employee of the Company for purposes of tax withholding under the Code whose customary employment with the Company or any Designated
Subsidiary is at least twenty (20) hours per week and more than five (5) months in any calendar year. For purposes of the Plan, the employment relationship shall be treated as continuing intact while the individual is on sick leave or
other leave of absence approved by the Company. Where the period of leave exceeds three (3) months and the individual’s right to reemployment is not guaranteed either by statute or by contract, the employment relationship will be deemed to
have terminated on the day three (3) months and one (1) day following the expiration of such three (3) month period. 
 (h) “Enrollment Date” shall mean the first Trading Day of each Offering Period. 
 (i) “Exercise Date” shall mean the last Trading Day of each Purchase Period. 

  
 1 

 (j) “Fair Market Value” shall mean, as of any date, the value of Common
Stock determined as follows: 
 (1) If the Common Stock is listed an any established stock exchange or a national market
system, including without limitation the National Market System of the National Association of Securities Dealers, Inc. Automated Quotation (“NASDAQ”) System, its Fair Market Value shall be the closing sale price for the Common Stock (or
the mean of the closing bid and asked prices, if no sales were reported), an quoted an such exchange (or the exchange with the greatest volume of trading in Common stock) or system on the date of such determination, as reported in The Wall Street
Journal or such other source as the Board deems reliable, or; 
 (2) If the Common Stock is quoted on the NASDAQ system (but
not on the National Market System thereof) or is regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair market value shall be the mean of the closing bid and asked prices for the Common Stock on the date of
such determination, as reported in The Wall Street Journal or such other source an the Board dooms reliable, or; 
 (3)
In the absence of an established market for the Common Stock, the Fair Market Value thereof shall be determined in good faith by the Board. 
 (4) For purposes of the Enrollment Date under the first Offering Period under the Plan, the Fair Market Value of the Common Stock shall be the Price to Public as set forth in the final prospectus filed
with the Securities and Exchange Commission pursuant to Rule 424 under the securities Act of 1933, as amended. 
 (k)
“Offering Period” shall mean the period of approximately twenty-four (24) months during which an option granted pursuant to the Plan may be exercised, commencing on the first Trading Day on or after January 1 and
July 1 of each year and terminating on the last Trading Day in the periods ending twenty-four months later, except that the first Offering Period shall be an extended Offering Period of approximately twenty-five months, commencing with the date
on which the Company’s registration statement on Form S-1 (or any successor form thereof) is declared effective by the Securities and Exchange Commission and ending on the last Trading Day in the period ending December 31, 1995. The second
Offering Period under the Plan shall commence with the first Trading Day on or after July 1, 1994. The duration of Offering Periods may be changed pursuant to Section 4 of this Plan. 

(l) “Plan” shall mean this Employee Stock Purchase Plan. 

(m) “Purchase Price” shall mean an amount equal to 85% of the Fair Market Value of a share of Common Stock on the
Enrollment Date or on the Exercise Date, whichever is lower. 
 (n) “Purchase Period” shall mean the
approximately six month period commencing after one Exercise Date and ending with the next Exercise Date, except that the first Purchase Period of any Offering Period shall commence on the Enrollment Date and end with the next Exercise Date;
provided, however, that the first Purchase Period of the first Offering Period under the Plan shall commence with the date on which the Company’s registration 

  
 2 

 
statement on Form S-1 (or any successor form thereof) is declared effective by the Securities and Exchange Commission and end on the last Trading Day occurring in the period ending June 30,
1994. 
 (o) “Reserves” shall mean the number of shares of Common Stock covered by each option under the Plan
which have not yet been exercised and the number of shares of Common Stock which have been authorized for issuance under the Plan but not yet placed under option. 
 (p) “Subsidiary” shall mean a corporation, domestic or foreign, of which not less than 50% of the voting shares are held by the Company or a Subsidiary, whether or not such corporation
now exists or is hereafter organized or acquired by the Company or a subsidiary. 
 (q) “Trading Day” shall
mean a day on which national stock exchanges and the National Association of Securities Dealers Automated Quotation (NASDAQ) System are open for trading. 
 3. Eligibility. 
 (a) Any Employee (as defined in Section 2(g)), who
shall be employed by the Company on a given Enrollment Date shall be eligible to participate in the Plan. 
 (b) Any Provisions
of the Plan to the contrary notwithstanding, no Employee shall be granted an option under the Plan (i) if, immediately after the grant, such Employee (or any other person whose stock would be attributed to such Employee pursuant to
Section 424(d) of the Code) would own capital stock of the Company and/or hold outstanding options to purchase such stock possessing five percent (5%) or more of the total combined voting power or value of all classes of the capital stock
of the Company or of any Subsidiary, or (ii) which permits his or her rights to purchase stock under all employee stock purchase plans of the Company and its subsidiaries to accrue at a rate which exceeds twenty-five thousand dollars ($25,000)
worth of stock (determined at the fair market value of the shares at the time such option is granted) for each calendar year in which such option is outstanding at any time. 
 4. Offering Periods. The Plan shall be implemented by consecutive, overlapping Offering Periods with a new Offering Period commencing on the first Trading Day on or after January 1 and
July 1 each year, or on such other date an the Board shall determine, and continuing thereafter until terminated in accordance with Section 19 hereof; provided, however, that the first Offering Period under the Plan shall be an extended
Offering Period of approximately twenty-five months, commencing with the first Trading Day on or after the date on which the Company’s registration statement on Form S-1 (or any successor form thereof) is declared effective by the Securities
and Exchange commission and ending on the last Trading Day in the period ending December 31, 1995. The second Offering Period under the Plan shall commence with the first Trading Day on or after July 1, 1994. The Board shall have the power
to change the duration of Offering Periods (including the commencement and termination dates thereof) with respect to future offerings without shareholder approval if such change is announced at least fifteen (15) days prior to the scheduled
beginning of the first Offering Period to be affected thereafter. 

  
 3 

 5. Participation. 

(a) An eligible Employee may become a participant in the Plan by completing a subscription agreement authorizing payroll deductions in
the form of Exhibit A to this Plan and filing it with the Company’s payroll office prior to the applicable Enrollment Date, unless a later time for filing the subscription agreement is set by the Board for all eligible Employees with respect to
a given Offering Period. 
 (b) Payroll deductions for a participant shall commence on the first payroll following the
Enrollment Date and shall end on the last payroll in the Offering Period to which such authorization is applicable, unless sooner terminated by the participant as provided in Section 10 hereof. 

6. Payroll Deductions. 
 (a) At the time a participant files his or her subscription agreement, he or she shall elect to have payroll deductions made on each pay day during the Offering Period in an amount not exceeding ten
percent (10%) of the Compensation which he or she receives on each pay day during the Offering Period, and the aggregate of such payroll deductions during the Offering Period shall not exceed ten percent (10%) of the participant’s
Compensation during said Offering Period. 
 (b) All payroll deductions made for a participant shall be credited to his or her
account under the Plan and will be credited withheld in whole percentages only. A participant may not make any additional payments into such account. 
 (c) A participant may discontinue his or her participation in the Plan as provided in Section 10 hereof, or may increase or decrease the rate of his or her payroll deductions during the Offering
Period by completing or filing with the Company a new subscription agreement authorizing a change in payroll deduction rate. The Board may, in its discretion, limit the number of participation rate changes during any Offering Period. The change in
rate shall be effective with the first full payroll period following five (5) business days after the Company’s receipt of the new subscription agreement unless the Company elects to process a given change in participation more quickly. A
participant’s subscription agreement shall remain in effect for successive Offering Periods unless terminated as provided in Section 10 hereof. 
 (d) Notwithstanding the foregoing, to the extent necessary to comply with Section 423 (b)(8) of the Code and Section 3(b) hereof, a participant’s payroll deductions may be decreased to 0%
at such time during any Purchase Period which is scheduled to end during the current calendar year (the “Current Purchase Period”) that the aggregate of all payroll deductions which were previously used to purchase stock under the Plan in
a prior Purchase Period which ended during that calendar year plus all payroll deductions accumulated with respect to the Current Purchase Period equal $21,250. Payroll deductions shall recommence at the rate provided in such participant’s
subscription agreement at the beginning of the first Purchase Period which is scheduled to end in the following calendar year, unless terminated by the participant as provided in Section 10 hereof. 

  
 4 

 (e) At the time the option is exercised, in whole or in part, or at the time some or all of
the Company’s Common Stock issued under the Plan is disposed of, the participant must make adequate provision for the Company’s federal, state, or other tax withholding obligations, if any, which arise upon the exercise of the option or
the disposition of the Common Stock. At any time, the Company may, but will not be obligated to, withhold from the participant’s cooperation the amount necessary for the Company to most applicable withholding obligations, including any
withholding required to make available to the Company any tax deductions or benefits attributable to sale or early disposition of Common Stock by the Employee. 
 7. Grant of Option. On the Enrollment Date of each Offering Period, each eligible Employee participating in such Offering Period shall be granted an option to purchase on each Exercise Date during
such Offering Period (at the applicable Purchase price) up to a number of shares of the Company’s Common Stock determined by dividing such Employee’s payroll deductions accumulated prior to such Exercise Date and retained in the
Participant’s account as of the Exercise Date by the applicable purchase Price; provided that in no event shall an Employee be permitted to purchase during each Purchase period more than a number of Shares determined by dividing $25,000 by the
Fair Market Value of a share of the Company’s Common Stock on the Enrollment Date; and provided further that such purchase shall be subject to the limitations set forth in Sections 3(b) and 12 hereof. Exercise of the option shall occur as
provided in Section 8 hereof, unless the participant has withdrawn pursuant to Section 10 hereof, and shall expire on the last day of the Offering Period. 
 8. Exercise of Option. Unless a participant withdraws from the Plan as provided in Section 10 hereof, his or her option for the purchase of shares will be exercised automatically on the
Exercise Date, and the maximum number of full shares subject to option shall be purchased for such participant at the applicable Purchase Price with the accumulated payroll deductions in his or her account. No fractional shares will be purchased;
any payroll deductions accumulated in a participant’s account which are not sufficient to purchase a full share shall be retained in the participant’s account for the subsequent Purchase Period or Offering Period, subject to earlier
withdrawal by the participant as provided in Section 10 hereof. Any other monies left over in a participant’s account after the Exercise Date shall be returned to the participant. During a participant’s lifetime, a participant’s
option to purchase shares hereunder is exercisable only by him or her. 
 9. Delivery. As promptly as practicable after
each Exercise Date on which a purchase of shares occurs, the Company shall arrange the delivery to each participant, as appropriate, of a certificate representing the shares purchased upon exercise of his or her option. 

10. Withdrawal; Termination of Employment. 
 (a) A participant may withdraw all but not less than all the payroll deductions credited to his or her account and not yet used to exercise his or her option under the Plan at any time by giving written
notice to the Company in the form of Exhibit B to this Plan. All of the participant’s payroll deductions credited to his or her account will be paid to such participant promptly after receipt of notice of withdrawal and such participant’s
option for the Offering Period will be automatically terminated, and no further payroll deductions for the purchase of shares will be made during the Offering Period. If a participant withdraws from an Offering Period, payroll deductions will not
resume at the beginning of the succeeding Offering Period unless the participant delivers to the Company a new subscription agreement. 

  
 5 

 (b) Upon a participant’s ceasing to be an Employee (as defined in Section 2(g)
hereof), for any reason, including by virtue of him or her having failed to remain an Employee of the Company for at least twenty (20) hours per week during an Offering Period in which the Employee is a participant, he or she will be deemed to
have elected to withdraw from the Plan and the payroll deductions credited to such participant’s account during the Offering Period but not yet used to exercise the option will be returned to such participant or, in the case of his or her
death, to the person or persons entitled thereto under Section 14 hereof, and such participant’s option will be automatically terminated. 
 11. Interest. No interest shall accrue on the payroll deductions of a participant in the Plan. 
 12. Stock. 
 (a) The maximum number of shares of the Company’s Common
Stock which shall be made available for sale under the Plan shall be 2,800,000 shares, subject to further adjustment upon changes in capitalization of the Company as provided in Section 18 hereof. If on a given Exercise Date the number of
shares with respect to which options are to be exercised exceeds the number of shares then available under the Plan, the Company shall make a pro rata allocation of the shares remaining available for purchase in as uniform a manner as shall be
practicable and as it shall determine to be equitable. 
 (b) The participant will have no interest or voting right in shares
covered by his option until such option has been exercised. 
 (c) Shares to be delivered to a participant under the Plan will
be registered in the name of the participant or in the name of the participant and his or her spouse. 
 13.
Administration. 
 (a) Administrative Body. The plan shall be administered by the Board or a committee of members
of the Board appointed by the Board. The Board or its committee shall have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to determine eligibility and to adjudicate all disputed claims filed under
the Plan. Every finding, decision and determination made by the Board or its committee shall, to the full extent permitted by law, be final and binding upon all parties. Members of the Board who are eligible Employees are permitted to participate in
the Plan, provided that: 
 (1) Members of the Board who are eligible to participate in the Plan may not vote on any matter
affecting the administration of the Plan or the grant of any option pursuant to the Plan. 
 (2) If a Committee is established
to administer the Plan, no member of the Board who is eligible to participate in the Plan may be a member of the Committee. 

  
 6 

 (b) Rule 16b-3 Limitations. Notwithstanding the provisions of Subsection (a) of
this Section 13, in the event that Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or any successor provision (“Rule 16b-3”) provides specific requirements for the
administrators of plans of this type, the Plan shall be only administered by such a body and in such a manner as shall comply with the applicable requirements of Rule 16b-3. Unless permitted by Rule 16b-3, no discretion concerning decisions
regarding the Plan shall be afforded to any committee or person that is not “disinterested” as that term is used in Rule 16b-3. 
 14. Designation of Beneficiary. 
 (a) A participant may file a written
designation of a beneficiary who is to receive any shares and cash, if any, from the participant’s account under the Plan in the event of such participant’s death subsequent to an Exercise Date on which the option is exercised but prior to
delivery to such participant of such shares and cash. In addition, a participant may file a written designation of a beneficiary who is to receive any cash from the participant’s account under the Plan in the event of such participant’s
death prior to exercise of the option. If a participant is married and the designated beneficiary is not the spouse, spousal consent shall be required for such designation to be effective. 

(b) Such designation of beneficiary may be changed by the participant at any time by written notice. In the event of the death of a
participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant’s death, the Company shall deliver such shares and/or cash to the executor or administrator of the estate of the
participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares and/or cash to the spouse or to any one or more dependents or relatives of the
participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. 
 15. Transferability. Neither payroll deductions credited to a participant’s account nor any rights with regard to the exercise of an option or to receive shares tinder the Plan may be
assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 14 hereof) by the participant. Any such attempt at assignment, transfer, pledge or other
disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds from an Offering Period in accordance with Section 10 hereof. 

16. Use of Funds. All payroll deductions received or held by the Company under the Plan may be used by the Company for corporate
purpose, and the Company shall not be obligated to segregate such payroll deductions. 
 17. Reports. Individual accounts
will be maintained for each participant in the Plan. Statements of account will be given to participating Employees at least annually, which statement will set forth the amounts of payroll deductions, the Purchase Price, the number of shares
purchased and the remaining cash balance, if any. 

  
 7 

 18. Adjustments Upon Changes in Capitalization, Dissolution, Liquidation, Merger or Asset
Sale. 
 (a) Changes in Capitalization. Subject to any required action by the shareholders of the Company, the
Reserves as well as the price per share of Common Stock covered by each option under the Plan which has not yet been exercised shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting
from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common stock, or any other increase or decrease in the number of shares of Common Stock effected without receipt of consideration by the Company,
provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.” Such adjustment shall be made by the Board, whose determination in that respect
shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof
shall be made with respect to, the number or price of shares of Common Stock subject to an option. 
 (b) Dissolution or
Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Offering Periods will terminate immediately prior to the consummation of such proposed action, unless otherwise provided by the Board. 

(c) Merger or Asset Sale. In the event of a proposed sale of all or substantially all of the assets of the Company, or the merger
of the Company with or into another corporation, each option under the Plan shall be assumed or an equivalent option shall be substituted by such successor corporation or a parent or subsidiary of such successor corporation, unless the Board
determines, in the exercise of its sole discretion and in lieu of such assumption or substitution, to shorten the Offering Periods then in progress by setting a new Exercise Date (the “New Exercise Date”). If the Board shortens the
Offering Periods then in progress in lieu of assumption or substitution in the event of a merger or sale of assets, the Board shall notify each participant in writing, at least ten (10) business days prior to the New Exercise Date, that the
Exercise Date for his option has been changed to the New Exercise Date and that his option will be exercised automatically on the New Exercise Date, unless prior to such date he has withdrawn from the Offering Period as provided in Section 10
hereof. For purposes of this paragraph, an option granted under the Plan shall be deemed to be assumed if, following the sale of assets or merger, the option confers the right to purchase, for each share of option stock subject to the option
immediately prior to the sale of assets or merger, the consideration (whether stock, cash or other securities or property) received in the sale of assets or merger by holders of common stock for each share of Common Stock held on the effective date
of the transaction (and if such holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of common Stock); provided, however, that if such consideration received in the
sale of assets or merger was not solely common stock of the successor corporation or its parent (as defined in Section 424(e) of the Code), the Board may, with the consent of the successor corporation and the participant, provide for the
consideration to be received upon exercise of the option to be solely common stock of the successor corporation or its parent equal in fair market value to the per share consideration received by holders of common stock and the sale of assets or
merger. 

  
 8 

 19. Amendment or Termination. 

(a) The Board of Directors of the Company may at any time and for any reason suspend, terminate or amend the Plan. Except as provided in
Section 18 and this Section 19, no such termination may affect options previously granted, provided that the Plan or any one or more Offering Periods may be terminated by the Board (or its committee) on any Exercise Date or by the Board
(or its committee) establishing a new Exercise Date with respect to any Offering Period and/or any Purchase Period then in progress if the Board (or its committee) determines that the termination of the Plan or such one or more Offering Periods is
in the best interests of the Company and its shareholders. Except as provided in Section 18 and this Section 19, no amendment may make any change in any option theretofore granted which adversely affects the rights of any participant
without the consent of the affected participants. To the extent necessary to comply with Section 423 of the Code (or any successor rule or provision or any other applicable law or regulation), the Company shall obtain shareholder approval in
such a manner and to such a degree as so required. 
 (b) Without shareholder consent and without regard to whether any
participant rights may be considered to have been “adversely affected,” the Board (or its committee) shall be entitled to limit the frequency and/or number of changes in the amount withheld during Offering Periods, change the length of
Purchase Periods within any Offering Period, determine the length of any future Offering Period, determine whether future Offering Periods shall be consecutive or overlapping, establish the exchange ratio applicable to amounts withheld in a currency
other than U.S. dollars, establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable non-U.S. jurisdictions, permit payroll withholding in excess of the amount designated by a participant in order to
adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the
purchase of Common Stock for each participant properly correspond with amounts withheld from the participant’s Compensation, and establish such other limitations or procedures as the Board (or its committee) determines in its sole discretion
advisable and which are consistent with the Plan. 
 20. Notices. All notices or other communications by a participant to
the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof. 

21. Conditions Upon Issuance of Shares. Shares shall not be issued with respect to an option unless the exercise of such option
and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as
amended, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance.

 As a condition to the exercise of an option, the Company may require the person exercising such option to represent and
warrant at the time of any such exercise that the shares 

  
 9 

 
are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by any
of the aforementioned applicable provisions of law. 
 22. Term of Plan. The Plan shall become effective upon the earlier
to occur of its adoption by the Board of Directors or its approval by the shareholders of the Company. It shall continue in effect until terminated under Section 19 hereof. 

23. Additional Restrictions of Rule 16b-3. The terms and conditions of options granted hereunder to, and the purchase of shares
by, persons subject to Section 16 of the Exchange Act shall comply with the applicable provisions of Rule 16b-3. This plan shall be deemed to contain, and such options shall contain, and the shares issued upon exercise thereof shall be subject
to, such additional conditions and restrictions as may be required by Rule 16b-3 to qualify for the maximum exemption from Section 16 of the Exchange Act with respect to Plan transactions. 

24. Automatic Transfer to Low Price Offering Period. To the extent permitted by Rule 16b-3 of the Exchange Act, if the Fair Market
Value of the Common Stock on any Exercise Date in an Offering Period is lower than the Fair Market Value of the Common Stock on the Enrollment Date of such Offering Period, then all participants in such Offering Period shall be automatically
withdrawn from such Offering Period immediately after the exercise of their option on such Exercise Date and automatically re-enrolled in the immediately following Offering Period as of the first day thereof. 

25. Plan Approval. The Plan was initially approved by the Board and the shareholders of the Company in the year 1993. Effective
January 1, 2004, the Board approved an amendment and restatement of the Plan to extend the term of the Plan, which amendment and restatement was not subject to shareholder approval. In March 28, 2006, the Board approved an amendment and
restatement of the Plan to increase the number of shares reserved for issuance under the Plan from 700,000 to 1,000,000 Shares, which amendment and restatement was subsequently approved by stockholders. In March 2008, the Board approved an amendment
and restatement of the Plan to increase the number of shares reserved for issuance under the Plan from 1,000,000 to 1,500,000 Shares, which amendment and restatement was subsequently approved by stockholders. In March 2009, the Board approved an
amendment and restatement of the Plan to increase the number of shares reserved for issuance under the Plan from 1,500,000 to 2,000,000 Shares, which amendment and restatement was subsequently approved by stockholders. In March 2010, the Board
approved an amendment and restatement of the Plan to increase the number of shares reserved for issuance under the Plan from 2,000,000 to 2,300,000 Shares, which amendment and restatement was subsequently approved by stockholders. In March 2011, the
Board approved an amendment and restatement of the Plan to increase the number of shares reserved for issuance under the Plan from 2,300,000 to 2,800,000 Shares, which amendment and restatement was subsequently approved by stockholders. 

  
 10 

 EXHIBIT A 
 DSP GROUP, INC. 
 1993 EMPLOYEE STOCK PURCHASE PLAN 

SUBSCRIPTION AGREEMENT 
  

					
	________	  	Original Application	  	Enrollment Date:                     
	________	  	Change in Payroll Deduction Rate	  	
	________	  	Change of Beneficiary(ies)	  	

  

	1.	                           
                                         
                                         
                                         
              hereby elects to Participate in the DSP Group, Inc. 1993 Employee Stock Purchase Plan (the “Employee Stock Purchase Plan”) and subscribes to purchase
shares of the Company’s Common Stock in accordance with this Subscription Agreement and the Employee Stock Purchase Plan. 

  

	2.	I hereby authorize payroll deductions from each paycheck in the amount of             % of my Compensation
on each payday (not to exceed 20%) during the Offering Period in accordance with the Employee Stock Purchase Plan. (Please note that no fractional percentages are permitted.) 

 

	3.	I understand that said payroll deductions shall be accumulated for the purchase of shares of Common Stock at the applicable Purchase Price determined in accordance with
the Employee Stock Purchase Plan. I understand that if I do not withdraw from an Offering Period, any accumulated payroll deductions will be used to automatically exercise my option. 

 

	4.	I have received a copy of the complete “DSP Group, Inc. 1993 Employee Stock Purchase Plan.” I understand that my participation in the Employee Stock Purchase
Plan is in all respects subject to the term of the Plan. I understand that the grant of the option by the Company under this Subscription Agreement is subject to obtaining shareholder approval of the Employee Stock Purchase Plan.

  

	5.	Shares purchased for me under the Employee Stock Purchase Plan should be issued in the name(s) of (Employee or Employee and spouse only):
                                         
                                         
                                         
                                         
.. 

  

	6.	 I understand that if I dispose of any shares received by me pursuant to the Plan within 2 years after the Enrollment Date (the first day of the
Offering Period during which I purchased such shares) or one year after the Exercise Date, I will be treated for federal income tax purposes as having received ordinary income at the time of such disposition in an amount equal to the excess of the
fair market value of the shares at the time such shares were purchased over the price which I paid far the shares. I hereby agree to notify the Company in writing within 30 days after the date of any disposition of my shares and I will make
adequate provision for Federal, state or other tax withholding obligations, if any, which arise upon the disposition of the Common  

  
 1 

	 	
Stock. The Company may, but will not be obligated to, withhold from my compensation the amount necessary to meet any applicable withholding obligation including any withholding
necessary to make available to the Company any tax deductions or benefits attributable to sale or early disposition of Common Stock by me. If I dispose of such shares at any time after the expiration of the 2-year and 1-year holding periods, I
understand that I will be treated for federal income tax purposes as having received income only at the time of such disposition, and that such income will be taxed as ordinary income only to the extent of an amount equal to the lesser of
(1) the excess of the fair market value of the shares at the time of such disposition over the purchase price which I paid for the shares, or (2) 15% of the fair market value of the shares on the first day of the Offering Period. The
remainder of the gain, if any, recognized on such disposition will be taxed as capital gain. 

  

	7.	I hereby agree to be bound by the terms of the Employee Stock Purchase Plan. The effectiveness of this Subscription Agreement is dependent upon my eligibility to
participate in the Employee Stock Purchase Plan. 

  

	8.	In the event of my death, I hereby designate the following as my beneficiary(ies) to receive all payments and shares due me under the Employee Stock Purchase Plan:

  

							
	NAME:    (Please print)	  	 	  	 	  	 
		  	(First)	  	(Middle)	  	(Last)

  

					
	  	 		 	  
	Relationship	 		 	
			
	 	 		 	  
		 		 	(Address)
			
	 Employee’s Social

Security Number:
	 		 	  
			
	Employee’s Address:	 		 	  
	 	 		 	  
	 	 		 	  

 I UNDERSTAND THAT THIS SUBSCRIPTION AGREEMENT SHALL REMAIN IN EFFECT THROUGHOUT SUCCESSIVE OFFERING PERIODS UNLESS
TERMINATED BY ME. 
  

					
	Dated:                     	 		 	  
		 		 	Signature of Employee
			
	 	 		 	  
		 		 	Spouse’s Signature (If beneficiary other than spouse)

  
 2 

 EXHIBIT B 
 DSP GROUP, INC. 
 1993 EMPLOYEE STOCK PURCHASE PLAN 

NOTICE OF WITHDRAWAL 
 The
undersigned participant in the Offering Period of the DSP Group, Inc. 1993 Employee Stock Purchase Plan which began on                     ,
            (the “Enrollment Date”) hereby notifies the company that he or she hereby withdraws from the Offering Period. He or she directs the Company to pay to the
undersigned as promptly as practicable all the payroll deductions credited to his or her account with respect to such Offering Period. The undersigned understands and agrees that his or her option for such Offering Period will be automatically
terminated. The undersigned understands further that no further payroll deductions will be made for the purchase of shares in the current Offering Period and the undersigned shall be eligible to participate in succeeding Offering Periods only by
delivering to the Company a new Subscription Agreement. 
  

			
	Name and Address of Participant:
	
	 
	
	 
	
	 
	
	Signature:
	
	 
		
	Date:	 	 

  
 1Employment Agreement by and between DSP Group, Ltd. and David Dahan

 Exhibit 10.41 

 
 

 
 To: 

David Dahan 

Re: Your Employment at DSP Group Ltd. 
 We are pleased to ask you to join DSP Group Ltd (hereinafter: the “Company”) in accordance with the following Employment Terms: 

 

	1.	Job Description 

  

	 	a.	Your position at the Company will be: COO 

  

	 	b.	Directly subordinate to: Ofer Elyakim, CEO 

  

	2.	Employment Terms 

 a. Salary

  

	1.	In consideration for your work at the Company, the Company will pay you the gross monthly sum of 62,600 New Israeli Shekels (hereinafter: “the Salary”),

 The Salary sum is gross and includes all the Salary components and various increases, and you will not be
entitled to receive any consideration or additional payment of any kind whatsoever, beyond the Salary, unless otherwise explicitly stated in this Agreement. 
  

	2.	The Salary will be updated in accordance with the updating rates of the cost of living increases in the economy. 

 

	3.	The company will pay you monthly travels reimbursement equivalent to NIS 500. 

 b. Directors Insurance 
  

	1.	The Company will allocate amounts from your Salary, as specified in Sections 2a.1 and 2a.2 above, for the pension fund or provident fund or Directors Insurance, at your
discretion, according to the following details: 

  

	 	a)	8.33% of the Salary on account of severance pay – at the Company’s expense. 

 

	 	b)	5% of the Salary on account of benefits—at the Company’s expense. 

 

	 	c)	5% of the Salary on account of benefits—at your expense 

  

	 	d)	Disability Income Insurance at the Company’s expense and in accordance with the Company’s procedures 

 

	2.	The company’s allocations for Directors Insurance as stated in Section 2b.1 above are on account of every other obligation to remit severance pay and/or
pension fund allocations, insofar as these exist according to law. 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

	3.	If, in the future, the Company is required by law and/or expansion order applicable to the entire economy to allocate sums for an arrangement or comprehensive pension
fund, this allocation will be intended for the fund or the applicable new arrangement, in lieu of the arrangement in this Agreement, and the Company will not be able to withdraw sums on account of the deposits made into the previous arrangement, but
rather subject to the regulations of the fund and/or other appropriate fund. 

 c. In-service Training Fund 

During your period of employment at the Company, it will allocate sums to a professional development fund. These allocations will be
calculated at the rate of 7.5% of your Salary on the Company’s account and at 2.5% of the Salary on the employee’s account. 
 d.
Annual Vacation 
  

	1.	During your employment period, you will be entitled to an annual vacation of 23 (twenty- three) working days. You must coordinate the time of your departure for
said vacation with your superior. 

  

	2.	Accumulation of vacation days for a duration exceeding the total vacation days due for two contractual years will not be allowed. 

 

	3.	The Company will be entitled to order you to take an annual vacation and use up to half of your annual vacation days, including departure for an organized, concentrated
vacation. 

 e. Sickness 
  

	1.	You are entitled to 30 (thirty) days’ sick leave per year, with the possibility of accumulating 3 (three) years’ sick leave, i.e. 90 (ninety) days.

  

	2.	Full payment for sick leave will be remitted from the first day. You must submit a doctor’s note. 

 

	3.	Accumulated sick leave may not be redeemed for money. 

 f. Reserve Duty 
  

	1.	Before taking time off for reserve duty, you must notify the Company upon receipt of your reserve duty order. 

 

	2.	The Salary for the reserve duty period will be paid to you in full, as stated above in this Agreement, subject to submission of an appropriate document verifying your
active reserve duty. 

 g. Your Eligibility for the Company’s Employee Option Plan 

The Company’s management will recommend that the DSP Group, Inc.’s Board of Directors grant you options to acquire 50,000 shares of the DSP
Group, Inc. common stock subject to the terms of the DSP Group Inc.’s employee stock option plan. 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

 In order to dispel any manner of doubt, it is hereby clarified that, in any case, approval to grant the
aforementioned options is subject to approval by the DSP Group, Inc.’s Board of Directors and the Authorities, as specified in the 
 h.
Annual Bonus 
 It is customary to allocate bonuses to some Company employees, and when management-level discussions of bonuses are held, the
Company will decide, at its sole discretion and in accordance with common practice among members of management, whether to discuss your eligibility for a bonus as well. 

 

	3.	The Contractual Period and its Termination 

  

	a.	This Agreement is valid as of the day it is signed by the parties to it. The contractual arrangement is for a period that is undetermined in advance. The beginning date
of your employment at the Company has hereby been determined as February 1, 2012. 

 Each party will be
entitled to terminate the contractual arrangement by informing the other party in writing 3 (three) month in advance. The Company reserves the right to refrain from exploiting the notification period and/or from terminating your employment
immediately. In this case, you will be paid an early notification fee equal to the Salary for the aforementioned period, on the basis of your last Salary. 
  

	c.	The Company will be entitled to terminate your employment without prior notification in the following cases: 

 

	 	1.	You have been convicted of a work-related criminal offense and/or an infamous offense. 

 

	 	2.	You have violated your duty of fidelity to the Company and/or committed an act constituting a conflict of interest. 

 

	 	3.	You have violated your obligation to maintain confidentiality as specified below in this Agreement and its appendices. 

 

	 	4.	You have maliciously harmed the Company or caused it damage in consequence of an act of gross negligence. 

 

	4.	Transfer of Allocations and Severance Pay 

Should your employment be terminated, the Company will transfer to you all the allocations that you have accumulated in your name in the Directors
Insurance Policy and/or the fund (hereinafter: the “Allocations”). In any case, should your employment be terminated under circumstances that entitle you to severance pay, the Company shall act in accordance with the Severance Pay Law,
5723-1963. 
 The following is a list of the reasons that will negate the transfer of the Company’s allocations in your name: 

 

	a.	The Company has dismissed you under circumstances entitling it to legally dismiss you without severance pay. 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

	b.	You have violated your fiduciary duty and/or duty of confidentiality toward the Company, under this Agreement, and without derogating from the generality of the
aforementioned— violation of the Confidentiality Agreement attached as Appendix A to this Agreement and which constitutes an integral part thereof. 

  

	c.	You have been convicted of a criminal offense and/or infamous offense. 

  

	d.	You have stopped working at the Company without giving the required advance notification specified in Section 3b above. 

 

	e.	You have stopped working at the Company without transferring your job, as specified in Section 7 below. 

It is hereby clarified that your transfer from the employment framework of the Company to that of a new company that is established—if established
as part of the Company—and your employment at such a company, will not constitute termination of your employment or your resignation and/or dismissal from the Company, for the purpose of transferring the various allocations, including severance
pay, yet without derogating from the generality of the aforementioned, unless a significant change in your job occurs. 
  

	5.	Working Hours 

  

	a.	Scope of position: 100% 

  

	b.	As your position is among those requiring a special degree of personal trust, as defined in the Working Hours and Rest Law, 5711—1951, you will not be subject to
the provisions of this law. From time to time, the requirements of your position will necessitate your working beyond the customary hours and on Fridays. In these cases, you will not be paid for overtime. 

 

	6.	The Duty of Fidelity and Avoidance of Conflicts of Interest 

  

	a.	You hereby undertake to carry out your job with dedication and fidelity; to use all your skills, knowledge and experience for the Company’s benefit and
advancement, at the highest, most efficient level and as the Company sees fit. In addition, you hereby undertake to act according to the Company’s instructions regarding everything related to the work performance, work arrangements, discipline
and conduct put into effect from time to time. 

  

	b.	 Once you begin working full time for the Company specified in Section 3a above, i.e. beginning on May 1st, 2007, you may not work at any other job and/or occupation as a
salaried employee and/or consultant and/or self-employed individual, be it directly and/or indirectly, unless you have the Company’s advance written approval to do so. In any case, you may not work in any capacity if said job conflicts with the
Company’s interests (a list of your current activities is attached as an appendix to this Agreement). 

  

	c.	Throughout the agreement period, you will not receive any payment or other benefit from any third party, be it directly or indirectly related to your job. It is hereby
clarified that a violation of this provision constitutes a violation of a fundamental condition of this Agreement, and, in addition, the aforementioned sum or benefit received by you will belong to the Company, which will be entitled to deduct the
said sum or the value of the benefit from all the sums due you from the Company. 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

	d.	You will not carry out any action that constitutes harm to your fidelity to the Company and/or is liable to place you in a position of conflict of interest vis—vis
the Company. You hereby undertake to immediately inform the Company of any matter or issue in which you have a personal stake and/or any other action that is liable to place you in the aforementioned position. 

 

	e.	Commencement of your employment pursuant to this Agreement is conditional upon your signature on the Confidentiality Agreement attached to this Agreement as Appendix A,
and constitutes an integral part thereof. 

  

	f.	You hereby undertake to inform the Company’s CEO of any business opportunity related in any way to the information specified in Appendix A. You undertake to
refrain from designating yourself or any other person for such an opportunity, be it directly or indirectly, unless the CEO has given his advance written approval for same. 

 

	7.	Transferring the Position 

 In the case of
termination of your job, and/or expiration of this Agreement for any reason whatsoever, you undertake to transfer your position—and without derogating from the generality of the aforesaid—and all the matters you handle and/or any
information whatsoever in your possession and which relates in any way to your job at the Company. Said transfer will be performed in an orderly and full manner, and include disclosure of any important detail regarding the Company’s dealings.
You further undertake to transfer to the Company all the documents, information, material, equipment, and the like, which you have received and/or prepared in relation to your job at the Company, up to termination of your job at the Company; said
transfer will be performed in an orderly and full manner. 
  

	8.	Declaration of Confidentiality 

 You
undertake to maintain confidentiality, both during and after your employment at the Company, as specified in the Pledge to Maintain Confidentiality attached to this Agreement as Appendix A, which constitutes an integral part thereof. 

 

	11.	Patents, Inventions and Trade Secrets 

  

	a.	The copyrights on any invention and/or patent and/or trade secret and/or professional secret and/or innovation whatsoever conceived by you and/or by any of the
Company’s employees subordinate to you during your Period of Employment at the Company and as part of your employment thereat will be the sole property of the Company. 

The Company will be entitled to protect an aforementioned invention and/or patent and/or trade secret by duly registering same or by
performing any other action, be it in Israel or anywhere else. 
 It is hereby clarified that you will not be entitled to
register the invention and/or patent and/or trade secret, or take any action related to them, except actions that are required for registration or exploitation of the aforementioned by or on behalf of the Company. The aforesaid will also apply to
the period following your employment at the Company. 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

	b.	You undertake to inform the Company, in writing, of any invention and/or patent and/or trade secret conceived by you and/or by any of the Company’s employees
subordinate to you, once you become aware of same. (A description of a patent-in-process is attached hereto.) 

  

	c.	The aforesaid in this section is supplementary to Appendix A of this Agreement. 

 On the occasion of signing this personal employment contract, we welcome you to the Company and wish you the utmost satisfaction from your job. 
 We hope this will mark the beginning of many years of cooperation between us for your own personal benefit as well as that of the Company. 
 Sincerely yours, 
 Tali Chen 
 VP Human Resources 
 DSP Group, Ltd. 
 I have read this letter carefully and hereby consent to its contents. 
 I know that the Salary
conditions I have been offered, and those that will prevail during my employment, are personal, and that this letter constitutes a personal, unique employment contract that formalizes my relationship with the Company; therefore, I hereby confirm my
knowledge of the fact that I will not be subject to the provisions of any other agreements, including collective-bargaining agreements, between the Company and its employees as long as this Agreement is valid, and I hereby undertake to maintain the
confidentiality of said conditions. 
 /s/ David Dahan 
 David Dahan 
 Signature 
 Date: 2/1/2012 
 ID No. 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

 Appendix A to My Employment Agreement with DSP Group Ltd 

Pledge of Confidentiality 
  

			
		
	Whereas	  	I hereby request to be employed at DSP Group Ltd (Private Company No. 511354722);
		
	and whereas	  	the Company has clarified to me the importance it attaches to the obligations specified in this document below, including everything related to the maintenance of confidentiality
(hereinafter: “the Obligations”);
		
	and whereas	  	the Company has conditioned my employment at the Company on my pledge to fulfill them;
		
	and whereas	  	the “Company” for the matter of this obligation also includes the American parent company, D.S.P. Group, Inc. (hereinafter: “the American Company”), the
subsidiaries of the Company and those of the American Company;
		
	and whereas	  	I know that the Company took said obligations into account when it determined my Salary and eligibility for employee options (hereinafter; “the Employment
Terms”)
		
	and whereas	  	I have given my full consent to the limitations stemming from the obligations, after having understood their meaning, examined their scope and weighed the consideration for
them;
		
	and whereas	  	the Employment Terms agreed to between myself and the Company constitute, from my viewpoint, proper consideration for the obligations;
		
	and whereas	  	I hereby take the obligations upon myself;
		
	and whereas	  	I hereby undertake to fulfill the obligations that I have assumed;
		
	and whereas	  	I know that, on the basis of the aforementioned, the Company has consented
		
	to	  	
		
		  	employ me;

 therefore, I hereby declare and undertake the following: 

 

	1.	The preamble to this document constitutes an integral part thereof. 

  

	2.	Confidentiality 

  

	 	2.1	 I hereby undertake to maintain full and total confidentiality regarding everything directly or indirectly related to the Company and its business,
including professional and/or commercial information related to the Company inclusive of the aforesaid, I hereby undertake, both regarding Israel and any other place outside of Israel, not to reveal or make available to others any information
whatsoever related to same in any form whatsoever, be it directly and/or indirectly, except information in the public domain (hereinafter: “the 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

	 	
Confidential Information”), and not to use said Confidential Information for my own personal needs or for the purpose of deriving any benefit for myself—or for others, be it during my
employment period at the Company or during any other subsequent period, when the 

 Confidential Information is
passed or revealed to me in consequence of my employment or during my aforesaid employment, be it by the Company, directly or indirectly, through hearing, sight or reading, including from third parties with whom the company deals, as well as when
the Confidential Information is the product of an idea or self-development during my employment period or as part of my aforesaid employment, except for the purpose of executing out my job during my employment period at the Company. 

In this Agreement—the Confidential Information regarding and/or concerning the Company, including technical and commercial know-how
and data (whether written or verbal), drafts, documents (reports, papers and records, assignation requests), descriptions, plans, software, hardware, trade secrets, including information related to the Company’s customers, suppliers and
business partners and/or to the Company’s production or marketing system, or which concerning the relations of the Company and/or its associated companies, control, are controlled, or are potentially or actually affiliated with any third
parties whatsoever, including customers, suppliers, banking institutions, governmental institutions, and private, quasi-public or public entities of any type, as well as any business, financial, commercial know-how, financial statements and balances
before their publication, and any internal information whatsoever that can affect the value of the Company’s shares, formulae, data, plans, patents, inventions, discoveries, innovations, improvements, research, methods of any kind, progress in
scientific, technical, economic, commercial or other developments, patent application letters, prototypes, samples, pictures, descriptions, blueprints, sketches, sun prints, booklets, models and specification documents, lists, documentation, source
and object codes, tapes, discs and other storage means, letters, records, record booklets, reports and flow charts, as well as information related to the Company’s current business and/or business that the Company is going to conduct (as it
will develop and as is described by the Company in its development plan booklet and business plans or in any other informational material on behalf of the Company) sales reports, short- and long-term policy covering Company-related, products,
product features, marketing methods, customer lists, price lists, discounts, supplier lists, business/commercial/financial contacts, economic calculations, including operating and product costs, and every other thing and matter that contains
Confidential Information or which is likely to serve as a source of Confidential Information, including any information of commercial, technical and non-technical value, be it written or unwritten, data, a set of lists, models, specification
documents, source and destination codes, processes, algorithms, computer magnetic tape, discs and other storage means that are tantamount to intellectual property or confidential material of the Company or of any of its predecessors or of its
associated companies, in whole or in part, and particularly including, without limitation, computer hardware, computer programmer’s plans and applications, price matters and marketing information, as well as inventions

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

 
that are not limited according to the definition of an invention as it is stipulated in the applicable Israeli or US patent laws, and each improvement or adaptation of the said information was
planned, developed or obtained by me or for the Company, directly or indirectly, provided that it is not information and/or an available product that is in the public domain or can be purchased freely from an independent third party, and everything
in relation to any matter related to the Company’s business and/or customers or which stems therefrom or is related in any way whatsoever, provided that is not in the public domain. 

 

	 	2.2	Without derogating from the generality of the aforesaid in Section 2.1 above, I hereby undertake not to reveal and/or transfer and/or sell – be it for
consideration or not for consideration—and/or to cause the exposure of the Confidential Information, directly or indirectly, and to take all the measures to maintain the confidentiality of the information and prevent said information from
reaching any third party whatsoever, person, body or corporation, other than my superiors at the Company or in accordance with their instructions for the purpose of fulfilling my duty as an employee of the Company. 

 

	 	2.3	I hereby undertake not to make any use of the information, be it in whole or in part, for my own needs or for other needs, directly or indirectly, other than for the
purpose of carrying out my tasks as an employee of the Company in accordance with the instructions given by my superiors, and not to make copies of the Confidential Information in any manner whatsoever or in any form whatsoever, except at the
instructions of the Company or anyone it has authorized to do so on its behalf. 

  

	 	2.4	I hereby undertake not to take any materials whatsoever that relate to the Confidential Information or the products, or any equipment from the Company, without
obtaining the advance express written consent of: (1) the Company’s president or CEO, or (2) a person who has been authorized to do so, in writing, by the Company’s president or CEO. 

 

	 	2.5	I know that my failure to safeguard any Confidential Information and/or my performance of an act construed as jeopardizing the security of the Confidential Information
will, for the matter of this document, be tantamount to passing on the Confidential Information without the Company’s consent, as stated above. 

  

	 	2.6	Without derogating from the statements above and below, I know that I do not, and will not, have any proprietary rights in the Confidential Information defined in this
document. 

  

	 	2.6.1	 I hereby undertake to inform the Company and/or those who come in its stead and/or its assignees of any inventions revealed to me during my Employment
Period at the Company and/or in consequence of my work at the Company, and are related to the Company’s business and/or to the Confidential Information, and I hereby assign every interest I have, or will have, in said inventions for the benefit
of the Company and/or those who come in its stead and/or its assignees, without receiving any 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

	 	
additional consideration for said assignation, provided that I will not be required to bear any expenses whatsoever for the aforementioned assignation. If I create an invention that is registered
as a patent either during my Employment Period at the Company or in consequence of my work at the Company, the Company will register my name on the patent documents as the inventor, provided that the Company is convinced beyond all doubt that the
invention was indeed created by me, and that said registration does not constitute an infringement upon the proprietary and/or other rights of the Company and/or those who come in its stead and/or its assignees, in said invention and/or patent
specified above. 

  

	 	2.6.2	I hereby undertake that, as long as I am required to do so, including during the period following termination of my employment for any reason whatsoever, I will sign
every document that the Company deems necessary for the submission of an application for a patent or copyrights in accordance with the laws of Israel, the US and/or any foreign country in order to protect the Company’s interest in the
aforementioned invention. 

  

	 	2.6.3	I hereby declare that, apart from the contents of Section below, I possess no interest in any patent or patent application whatsoever, and not even in material subject
to the copyrights, patents and patent applications urrently belonging to me. 

  

	 	2.6.4	Existing patents and/or pending patent applications, and/or research activities at the stage of patent registration submission: 

 

							
		 	1.	 	  
	 	
		 	2.	 	  
	 	
		 	3.	 	  
	 	
		 	4.	 	  
	 	

  

	 	2.7	I know that disclosure of the Confidential Information and/or any part thereof to any third party whatsoever is liable to cause the Company severe damage, and I hereby
undertake that I will not, in any way, perform an action involving a transfer and/or sale of the information and/or the products developed by the Company and/or existing products and/or which have been developed either by myself, in cooperation with
others—including customers of the Company—or in cooperation with any third party whatsoever, to customers of the Company or to others. 

  

	 	2.8	I hereby declare my understanding that the nature of the Company’s business is such that, by entering into contractual arrangements with third parties, it
undertakes and/or is likely to undertake confidentiality obligations that also apply to its employees, and non-fulfillment of the aforementioned obligations will constitute, among other things, a contract violation between the Company and the third
party. I hereby undertake, therefore, to fulfill all said obligations as stipulated between the Company and the third party, as stated above. 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206 

 

 
  

	 	2.9	I hereby undertake not to directly or indirectly damage the Company’s reputation of and/or its status among its actual and potential customers. I hereby undertake
to safeguard the confidentiality of information related to all the financial aspects of the Company’s activity, including relations with banking institutions and the customs and tax authorities, and the Company’s liabilities and rights
vis—vis third parties. Furthermore, I will safeguard the confidentiality of the information that comes into my hands and is related to entities such as the investment center, the Chief Scientist, the Company’s accountants and legal
advisors, and the like. 

  

	 	2.10	In order to dispel any manner of doubt, it is hereby stressed that my obligations as stated above will be in effect both during my Employment Period at the Company and
following termination of my employment at the Company for any reason whatsoever, and will also obligate my legal representatives, without time limitations. 

 

	 	2.11	I hereby agree that each document I have prepared and/or information I have obtained for the purpose of performing my job at the Company during my Employment Period at
the Company is the Company’s property that will be transferred to the Company immediately following my employment as specified below. Furthermore, I hereby undertake to return to the Company all information—be it in written or any other
form—that is or will be in my possession at any time, and I will do so immediately following conclusion of my employment for any reason whatsoever, or immediately on demand by the Company at any time. 

 

	 	3.	I again hereby declare my knowledge of the fact that the obligations in this document are especially important to the Company and constituted a precondition to my
employment and were taken into account when the Company determined the Employment Terms, and that I fully consented to the limitations stemming therefrom after having understood their meaning, examined their scope, and weighed the consideration for
them; therefore, I know that any violation of the obligations I have taken upon myself will grant the Company all the legal rights and remedies. 

 /s/ David Dahan 
 David Dahan 
 Employee’s Signature 
 Date: 2/1/2012 

  
 5 Shenkar St. Herzeliya
46120, Israel 
 Tel:+972-9-952-9696 

Fax:+972-9-954-1234 
 sf-3107206

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}]]